(a)
| Characteristic | Mean preoperative NLR (SD) | P value |
|---|---|---|
| Age | 2.8 (1.4) | <0.01a |
| Gender | <0.01b | |
| Male | 3.0 (1.4) | |
| Female | 2.6 (1.3) | |
| Race | <0.01b | |
| Caucasian | 2.9 (1.4) | |
| African American | 1.9 (0.9) | |
| Other | 2.7 (1.6) | |
| ASA score | 0.18b | |
| I-II | 2.8 (1.4) | |
| III-IV | 2.9 (1.5) | |
| Preoperative Crea | 2.8 (1.4) | <0.01a |
| Preoperative eGFR | 2.8 (1.4) | <0.01a |
| Pathology | 0.75b | |
| Benign | 2.9 (1.4) | |
| Malignant | 2.8 (1.3) | |
| Pathological subtypes | 0.34b | |
| Benign | ||
| Oncocytoma | 2.9 (1.4) | |
| Angiomyolipoma | 2.8 (1.4) | |
| Other benign | 2.7 (1.2) | |
| Malignant | ||
| Conventional RCC | 2.8 (1.3) | |
| Papillary RCC | 3.1 (1.7) | |
| Chromophobe RCC | 2.5 (1.1) | |
| Cystic RCC | 3.1 (2.3) | |
| Unclassified RCC | 2.5 (1.3) | |
| Other malignant | 2.3 (0.9) |
aMeasure of association by Spearman correlation.
bMeasure of association by Kruskal-Wallis test.